kind patches glp-1 patches review UK Review: Kind Patches #GLP1 Review: Weight
Description
While this signal reached weak statistical significance when stratifying the follow-up into early and late phases, such findings must be interpreted with caution
Nature (1997) 389:81624
Gao L, Peng L, Wang J, et al
For clients whove been covering GLP-1s and watching costs climb, this is the off-ramp a way to step back from the high-list-price model without eliminating the benefit
Even large pharma may partner: Novo Nordisk historically used Catalent and Lonza for fill-finish
